TE
RVMD icon

Tema ETFs’s Revolution Medicines RVMD Stock Holding History

Tema ETFs’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.4M Sell
71,735
-26,443
-27% -$3.86M 0.43% 57
2026
Q1 		$9.55M Sell
98,178
-2,425
-2% -$245K 0.64% 47
2025
Q4 		$8.01M Sell
100,603
-26,318
-21% -$1.73M 0.62% 45
2025
Q3 		$5.93M Buy
126,921
+32,694
+35% +$1.28M 0.49% 59
2025
Q2 		$3.47M Sell
94,227
-351
-0.4% -$13.5K 0.92% 39
2025
Q1 		$3.34M Buy
94,578
+49,056
+108% +$1.99M 1% 25
2024
Q4 		$1.99M Buy
+45,522
New +$2.3M 0.83% 36

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Tema ETFs's RVMD Position: Q2 2026 in Review

Tema ETFs reduced its Revolution Medicines (RVMD) stake by 27% in Q2 2026, selling an estimated $3.86M and leaving 71,735 shares worth $13.4M. The position accounts for 0.43% of the portfolio, ranked #57.

Tema ETFs first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Tema ETFs held 71,735 shares of Revolution Medicines worth $13.4M as of Q2 2026.
  • Tema ETFs sold 26,443 Revolution Medicines shares in Q2 2026, an estimated $3.86M.
  • Revolution Medicines made up 0.43% of Tema ETFs's portfolio in Q2 2026, its #57 holding.
  • Tema ETFs first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.